Rong Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rong Guo has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Dongyi Xu
Peking University
9 shared publications Shaokai Ning
State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China
5 shared publications- Yixi Xu
State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China
4 shared publications - Qing Li
State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences and Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China
3 shared publications Ruiyuan Guo
State Key Laboratory of Gene Function and Modulation Research, Beijing Advanced Center of RNA Biology (BEACON), School of Life Sciences, Peking University, Beijing, China
3 shared publicationsSumin Feng
State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China
3 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Springer Nature in Cell Death & Disease
Folate stress as a contributing factor to Fanconi anemia
Fanconi anemia (FA) is a rare chromosomal instability disorder characterized by progressive bone marrow failure, congenital abnormalities, and a heightened cancer predisposition. With at least 23 identified FA genes, biallelic mutations in any one of these genes disrupt the FA pathway, a specialized DNA repair mechanism, leading to disease pathogenesis. FA cells are hypersensitive to DNA interstrand crosslinks (ICLs), which have been linked to endogenous aldehydes and oxidative stress, both contributing factors to FA pathogenesis. Our previous work identified replication stress as a significant driver of FA pathology, demonstrating that FA-deficient cells are particularly vulnerable to persistent replication stress. Here, we reveal that folate deficiency, a condition impairing DNA synthesis, repair, and methylation, constitutes a previously unrecognized contributing factor to FA. We show that folate stress causes aberrant DNA replication in FA-deficient cells, leading to chromosomal loss and proliferation delay. Mechanistically, the FA pathway is activated under folate stress and engages a break-induced replication (BIR)-like process to mitigate replication-associated damage. Importantly, feeding Fancl -/- mice a folate-deficient diet induced bone marrow failure, recapitulating a hallmark FA symptom. Our findings suggest that folate supplementation may offer a potential strategy for ameliorating FA symptoms.
- 2 November 2026
- Published by Springer Nature in Cell Death & Disease
Open AccessFolate stress as a contributing factor to Fanconi anemia
Fanconi anemia (FA) is a rare chromosomal instability disorder characterized by progressive bone marrow failure, congenital abnormalities, and a heightened cancer predisposition. With at least 23 identified FA genes, biallelic mutations in any one of these genes disrupt the FA pathway, a specialized DNA repair mechanism, leading to disease pathogenesis. FA cells are hypersensitive to DNA interstrand crosslinks (ICLs), which have been linked to endogenous aldehydes and oxidative stress, both contributing factors to FA pathogenesis. Our previous work identified replication stress as a significant driver of FA pathology, demonstrating that FA-deficient cells are particularly vulnerable to persistent replication stress. Here, we reveal that folate deficiency, a condition impairing DNA synthesis, repair, and methylation, constitutes a previously unrecognized contributing factor to FA. We show that folate stress causes aberrant DNA replication in FA-deficient cells, leading to chromosomal loss and proliferation delay. Mechanistically, the FA pathway is activated under folate stress and engages a break-induced replication (BIR)-like process to mitigate replication-associated damage. Importantly, feeding Fancl -/- mice a folate-deficient diet induced bone marrow failure, recapitulating a hallmark FA symptom. Our findings suggest that folate supplementation may offer a potential strategy for ameliorating FA symptoms.
- Open Access
- 17 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
RIF1-ASF1-mediated high-order chromatin structure safeguards genome integrity
The 53BP1-RIF1 pathway antagonizes resection of DNA broken ends and confers PARP inhibitor sensitivity on BRCA1-mutated tumors. However, it is unclear how this pathway suppresses initiation of resection. Here, we identify ASF1 as a partner of RIF1 via an interacting manner similar to its interactions with histone chaperones CAF-1 and HIRA. ASF1 is recruited to distal chromatin flanking DNA breaks by 53BP1-RIF1 and promotes non-homologous end joining (NHEJ) using its histone chaperone activity. Epistasis analysis shows that ASF1 acts in the same NHEJ pathway as RIF1, but via a parallel pathway with the shieldin complex, which suppresses resection after initiation. Moreover, defects in end resection and homologous recombination (HR) in BRCA1-deficient cells are largely suppressed by ASF1 deficiency. Mechanistically, ASF1 compacts adjacent chromatin by heterochromatinization to protect broken DNA ends from BRCA1-mediated resection. Taken together, our findings identify a RIF1-ASF1 histone chaperone complex that promotes changes in high-order chromatin structure to stimulate the NHEJ pathway for DSB repair.
- 17 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Open AccessRIF1-ASF1-mediated high-order chromatin structure safeguards genome integrity
The 53BP1-RIF1 pathway antagonizes resection of DNA broken ends and confers PARP inhibitor sensitivity on BRCA1-mutated tumors. However, it is unclear how this pathway suppresses initiation of resection. Here, we identify ASF1 as a partner of RIF1 via an interacting manner similar to its interactions with histone chaperones CAF-1 and HIRA. ASF1 is recruited to distal chromatin flanking DNA breaks by 53BP1-RIF1 and promotes non-homologous end joining (NHEJ) using its histone chaperone activity. Epistasis analysis shows that ASF1 acts in the same NHEJ pathway as RIF1, but via a parallel pathway with the shieldin complex, which suppresses resection after initiation. Moreover, defects in end resection and homologous recombination (HR) in BRCA1-deficient cells are largely suppressed by ASF1 deficiency. Mechanistically, ASF1 compacts adjacent chromatin by heterochromatinization to protect broken DNA ends from BRCA1-mediated resection. Taken together, our findings identify a RIF1-ASF1 histone chaperone complex that promotes changes in high-order chromatin structure to stimulate the NHEJ pathway for DSB repair.
- 16 October 2021
- Published by Springer Nature in Genome Instability & Disease
- Vol. 2 (5) , 281-291
The emergence of a unified mechanism in the Fanconi anemia pathway
- 16 October 2021
- Published by Springer Nature in Genome Instability & Disease
- Vol. 2 (5) , 281-291
The emergence of a unified mechanism in the Fanconi anemia pathway
- 10 June 2021
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 28 (6) , 487-500
Fanconi anemia proteins participate in a break-induced-replication-like pathway to counter replication stress
Fanconi anemia (FA) is a devastating hereditary disease characterized by bone marrow failure (BMF) and acute myeloid leukemia (AML). As FA-deficient cells are hypersensitive to DNA interstrand crosslinks (ICLs), ICLs are widely assumed to be the lesions responsible for FA symptoms. Here, we show that FA-mutated cells are hypersensitive to persistent replication stress and that FA proteins play a role in the break-induced-replication (BIR)-like pathway for fork restart. Both the BIR-like pathway and ICL repair share almost identical molecular mechanisms of 53BP1–BRCA1-controlled signaling response, SLX4- and FAN1-mediated fork cleavage and POLD3-dependent DNA synthesis, suggesting that the FA pathway is intrinsically one of the BIR-like pathways. Replication stress not only triggers BMF in FA-deficient mice, but also specifically induces monosomy 7, which is associated with progression to AML in patients with FA, in FA-deficient cells.
- 10 June 2021
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 28 (6) , 487-500
Fanconi anemia proteins participate in a break-induced-replication-like pathway to counter replication stress
Fanconi anemia (FA) is a devastating hereditary disease characterized by bone marrow failure (BMF) and acute myeloid leukemia (AML). As FA-deficient cells are hypersensitive to DNA interstrand crosslinks (ICLs), ICLs are widely assumed to be the lesions responsible for FA symptoms. Here, we show that FA-mutated cells are hypersensitive to persistent replication stress and that FA proteins play a role in the break-induced-replication (BIR)-like pathway for fork restart. Both the BIR-like pathway and ICL repair share almost identical molecular mechanisms of 53BP1–BRCA1-controlled signaling response, SLX4- and FAN1-mediated fork cleavage and POLD3-dependent DNA synthesis, suggesting that the FA pathway is intrinsically one of the BIR-like pathways. Replication stress not only triggers BMF in FA-deficient mice, but also specifically induces monosomy 7, which is associated with progression to AML in patients with FA, in FA-deficient cells.
- 8 October 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (43) , 201806665-E10088
Mitosis-specific MRN complex promotes a mitotic signaling cascade to regulate spindle dynamics and chromosome segregation
Significance: The Mre11–Rad50–Nbs1 (MRN) complex is well known for participating in DNA damage response pathways and mediating the ATM-dependent phosphorylation signaling cascade. Hypomorphic mutations in the human MRN complex have been identified in autosomal recessive genetic diseases, ataxia-telangiectasia–like disorder, and Nijmegen breakage syndrome. Here, we show that MRN forms a mitosis-specific complex with a protein, MMAP, which mediates a mitotic signaling cascade between PLK1 and KIF2A. We demonstrate that the assembly of this complex is crucial for normal spindle dynamics during mitosis. Thus, our study describes a signaling cascade in which PLK1-dependent phosphorylation promotes the assembly of the MRN–MMAP–PLK1–KIF2A complex, leading to mitotic spindle turnover and chromosome alignment.
- 8 October 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (43) , 201806665-E10088
Mitosis-specific MRN complex promotes a mitotic signaling cascade to regulate spindle dynamics and chromosome segregation
Significance: The Mre11–Rad50–Nbs1 (MRN) complex is well known for participating in DNA damage response pathways and mediating the ATM-dependent phosphorylation signaling cascade. Hypomorphic mutations in the human MRN complex have been identified in autosomal recessive genetic diseases, ataxia-telangiectasia–like disorder, and Nijmegen breakage syndrome. Here, we show that MRN forms a mitosis-specific complex with a protein, MMAP, which mediates a mitotic signaling cascade between PLK1 and KIF2A. We demonstrate that the assembly of this complex is crucial for normal spindle dynamics during mitosis. Thus, our study describes a signaling cascade in which PLK1-dependent phosphorylation promotes the assembly of the MRN–MMAP–PLK1–KIF2A complex, leading to mitotic spindle turnover and chromosome alignment.
- Open Access
- 25 September 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 3925
An OB-fold complex controls the repair pathways for DNA double-strand breaks
53BP1 with its downstream proteins, RIF1, PTIP and REV7, antagonizes BRCA1-dependent homologous recombination (HR) and promotes non-homologous end joining (NHEJ) in an unclear manner. Here we show that REV7 forms a complex with two proteins, FAM35A and C20ORF196. We demonstrate that FAM35A preferentially binds single-strand DNA (ssDNA) in vitro, and is recruited to DSBs as a complex with C20ORF196 and REV7 downstream of RIF1 in vivo. Epistasis analysis shows that both proteins act in the same pathway as RIF1 in NHEJ. The defects in HR pathway to repair DSBs and the reduction in resection of broken DNA ends in BRCA1-mutant cells can be largely suppressed by inactivating FAM35A or C20ORF196, indicating that FAM35A and C20ORF196 prevent end resection in these cells. Together, our data identified a REV7–FAM35A–C20ORF196 complex that binds and protects broken DNA ends to promote the NHEJ pathway for DSB repair.
- 25 September 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 3925
Open AccessAn OB-fold complex controls the repair pathways for DNA double-strand breaks
53BP1 with its downstream proteins, RIF1, PTIP and REV7, antagonizes BRCA1-dependent homologous recombination (HR) and promotes non-homologous end joining (NHEJ) in an unclear manner. Here we show that REV7 forms a complex with two proteins, FAM35A and C20ORF196. We demonstrate that FAM35A preferentially binds single-strand DNA (ssDNA) in vitro, and is recruited to DSBs as a complex with C20ORF196 and REV7 downstream of RIF1 in vivo. Epistasis analysis shows that both proteins act in the same pathway as RIF1 in NHEJ. The defects in HR pathway to repair DSBs and the reduction in resection of broken DNA ends in BRCA1-mutant cells can be largely suppressed by inactivating FAM35A or C20ORF196, indicating that FAM35A and C20ORF196 prevent end resection in these cells. Together, our data identified a REV7–FAM35A–C20ORF196 complex that binds and protects broken DNA ends to promote the NHEJ pathway for DSB repair.
- Open Access
- 6 November 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
53BP1 and BRCA1 control pathway choice for stalled replication restart
The cellular pathways that restart stalled replication forks are essential for genome stability and tumor prevention. However, how many of these pathways exist in cells and how these pathways are selectively activated remain unclear. Here, we describe two major fork restart pathways, and demonstrate that their selection is governed by 53BP1 and BRCA1, which are known to control the pathway choice to repair double-strand DNA breaks (DSBs). Specifically, 53BP1 promotes a fork cleavage-free pathway, whereas BRCA1 facilitates a break-induced replication (BIR) pathway coupled with SLX-MUS complex-mediated fork cleavage. The defect in the first pathway, but not DSB repair, in a 53BP1 mutant is largely corrected by disrupting BRCA1, and vice versa. Moreover, PLK1 temporally regulates the switch of these two pathways through enhancing the assembly of the SLX-MUS complex. Our results reveal two distinct fork restart pathways, which are antagonistically controlled by 53BP1 and BRCA1 in a DSB repair-independent manner.
- 6 November 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Open Access53BP1 and BRCA1 control pathway choice for stalled replication restart
The cellular pathways that restart stalled replication forks are essential for genome stability and tumor prevention. However, how many of these pathways exist in cells and how these pathways are selectively activated remain unclear. Here, we describe two major fork restart pathways, and demonstrate that their selection is governed by 53BP1 and BRCA1, which are known to control the pathway choice to repair double-strand DNA breaks (DSBs). Specifically, 53BP1 promotes a fork cleavage-free pathway, whereas BRCA1 facilitates a break-induced replication (BIR) pathway coupled with SLX-MUS complex-mediated fork cleavage. The defect in the first pathway, but not DSB repair, in a 53BP1 mutant is largely corrected by disrupting BRCA1, and vice versa. Moreover, PLK1 temporally regulates the switch of these two pathways through enhancing the assembly of the SLX-MUS complex. Our results reveal two distinct fork restart pathways, which are antagonistically controlled by 53BP1 and BRCA1 in a DSB repair-independent manner.
- Open Access
- 1 October 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (42) , 21956-21962
Ewing Tumor-associated Antigen 1 Interacts with Replication Protein A to Promote Restart of Stalled Replication Forks
- 1 October 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (42) , 21956-21962
Open AccessEwing Tumor-associated Antigen 1 Interacts with Replication Protein A to Promote Restart of Stalled Replication Forks
- 1 July 2016
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 48 (7) , 632-640
Non-homologous end joining: advances and frontiers
DNA double-strand breaks (DSBs) are the most serious form of DNA damage. In human cells, non-homologous end joining (NHEJ) is the major pathway for the repair of DSBs. Different types of DSBs result in different subsets of NHEJ repair strategies. These variations in NHEJ repair strategies depend on numerous elements, such as the flexible recruitment of NHEJ-related proteins, the complexity of the DSB ends, and the spatial- and temporal-ordered formation of the multi-protein complex. On the one hand, current studies of DNA DSBs repair focus on the repair pathway choices between homologous recombination and classic or alternative NHEJ. On the other hand, increasing researches have also deepened the significance and dug into the cross-links between the NHEJ pathway and the area of genome organization and aging. Although remarkable progress has been made in elucidating the underlying principles during the past decades, the detailed mechanism of action in response to different types of DSBs remains largely unknown and needs further evaluation in the future study.
- 1 July 2016
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 48 (7) , 632-640
Non-homologous end joining: advances and frontiers
DNA double-strand breaks (DSBs) are the most serious form of DNA damage. In human cells, non-homologous end joining (NHEJ) is the major pathway for the repair of DSBs. Different types of DSBs result in different subsets of NHEJ repair strategies. These variations in NHEJ repair strategies depend on numerous elements, such as the flexible recruitment of NHEJ-related proteins, the complexity of the DSB ends, and the spatial- and temporal-ordered formation of the multi-protein complex. On the one hand, current studies of DNA DSBs repair focus on the repair pathway choices between homologous recombination and classic or alternative NHEJ. On the other hand, increasing researches have also deepened the significance and dug into the cross-links between the NHEJ pathway and the area of genome organization and aging. Although remarkable progress has been made in elucidating the underlying principles during the past decades, the detailed mechanism of action in response to different types of DSBs remains largely unknown and needs further evaluation in the future study.
- 13 August 2006
- Published by Springer Nature in Nature
- Vol. 443 (7108) , 222-225
Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo
The ATM (ataxia telangiectasia mutated) protein kinase is activated under physiological and pathological conditions that induce DNA double-strand breaks (DSBs). Loss of ATM or failure of its activation in humans and mice lead to defective cellular responses to DSBs, such as cell cycle checkpoints, radiation sensitivity, immune dysfunction, infertility and cancer predisposition. A widely used biological marker to identify the active form of ATM is the autophosphorylation of ATM at a single, conserved serine residue (Ser 1981 in humans; Ser 1987 in mouse)1. Here we show that Atm-dependent responses are functional at the organismal and cellular level in mice that express a mutant form of Atm (mutation of Ser to Ala at position 1987) as their sole Atm species. Moreover, the mutant protein does not exhibit dominant-negative interfering activity when expressed physiologically or overexpressed in the context of Atm heterozygous mice. These results suggest an alternative mode for stimulation of Atm by DSBs in which Atm autophosphorylation at Ser 1987, like trans-phosphorylation of downstream substrates, is a consequence rather than a cause of Atm activation.
- 13 August 2006
- Published by Springer Nature in Nature
- Vol. 443 (7108) , 222-225
Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo
The ATM (ataxia telangiectasia mutated) protein kinase is activated under physiological and pathological conditions that induce DNA double-strand breaks (DSBs). Loss of ATM or failure of its activation in humans and mice lead to defective cellular responses to DSBs, such as cell cycle checkpoints, radiation sensitivity, immune dysfunction, infertility and cancer predisposition. A widely used biological marker to identify the active form of ATM is the autophosphorylation of ATM at a single, conserved serine residue (Ser 1981 in humans; Ser 1987 in mouse)1. Here we show that Atm-dependent responses are functional at the organismal and cellular level in mice that express a mutant form of Atm (mutation of Ser to Ala at position 1987) as their sole Atm species. Moreover, the mutant protein does not exhibit dominant-negative interfering activity when expressed physiologically or overexpressed in the context of Atm heterozygous mice. These results suggest an alternative mode for stimulation of Atm by DSBs in which Atm autophosphorylation at Ser 1987, like trans-phosphorylation of downstream substrates, is a consequence rather than a cause of Atm activation.